Stockreport

Tempus and Medtronic Announce ALERT Trial Results Showing AI-Driven EHR Notifications Improve Treatment for Significant Valvular Heart Disease [Yahoo! Finance]

Tempus AI, Inc. - Class A  (TEM) 
PDF notification system designed to address the undertreatment of significant valvular heart disease and accelerate time to treatment. CHICAGO, April 01, 2026 BUSINESS WIR [Read more]